Companies:
54,042
Total Market Cap:
171475362932362.48
Global Rank
#14625
Country Rank
#3
Market Cap
523.29 M
Price
5.17
Change (%)
0.00%
Volume
1,430
Tchaikapharma High Quality Medicines AD's latest marketcap:
523.29 M
As of 10/14/2026, Tchaikapharma High Quality Medicines AD's market capitalization has reached $523.29 M. According to our data, Tchaikapharma High Quality Medicines AD is the 14625th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 523.29 M |
| Revenue (ttm) | 21.88 M |
| Net Income (ttm) | 1.87 M |
| Shares Out | 101.3 M |
| EPS (ttm) | 0.02 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 10/28/2026 |
Market Cap Chart
Data Updated: 10/14/2026
Tchaikapharma High Quality Medicines AD's yearly market capitalization.
Tchaikapharma High Quality Medicines AD has seen its market value grow from 270.05 M BGN to 876.25 M BGN since 2015, representing a total increase of 224.47% and an annual compound growth rate (CAGR) of 11.52%.
| Date | Market Cap | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 10/16/2026 | 876.25 M | $0 | -2.75% | n/a |
| 12/22/2025 | 900.98 M | $534.83 M | 6.63% | 9747 |
| 12/27/2024 | 844.97 M | $448.41 M | 9.56% | 9527 |
| 12/06/2023 | 771.24 M | $435.35 M | 10.9% | 9600 |
| 12/30/2022 | 695.42 M | $378.89 M | 8.02% | 9905 |
| 12/29/2021 | 643.77 M | $372.48 M | -43.57% | 11120 |
| 12/23/2020 | 1.14 B | $715.15 M | 27.32% | 9663 |
| 12/19/2019 | 895.98 M | $514.19 M | 37.89% | 9899 |
| 12/28/2018 | 649.8 M | $380.09 M | 28.08% | 10507 |
| 12/29/2017 | 507.33 M | $310.83 M | 28.6% | 12732 |
Company Profile
Tchaikapharma High Quality Medicines AD
Industry: Pharmaceuticals
Founded: 1999
Headquarters: Sofia, Bulgaria
Tchaikapharma High Quality Medicines AD specializes in the development and manufacturing of generic and in-licensed pharmaceutical products.
Key Offerings
- Anaesthetic medicines
- Anti-inflammatory and anti-rheumatic drugs
- Antibiotics
- Cardiovascular system medications
- Digestive system treatments
- Diabetes and metabolism therapies
- Nervous system medicines
- Over-the-counter (OTC) products
- Respiratory system solutions
- Oncology treatments
- Nutritional supplements
The company serves both domestic and international markets with high-quality pharmaceutical solutions.
Frequently Asked Questions
-
What is Tchaikapharma High Quality Medicines AD's (BUL-THQM) current market cap?As of 10/14/2026, Tchaikapharma High Quality Medicines AD (including the parent company, if applicable) has an estimated market capitalization of $523.29 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Tchaikapharma High Quality Medicines AD (BUL-THQM) rank globally by market cap?Tchaikapharma High Quality Medicines AD global market capitalization ranking is approximately 14625 as of 10/14/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.